Abstract

This study focuses on the use of blockchain data security technology and its application in pharmaceutical companies, providing a theoretical foundation for achieving digitalization, efficient traceability, and ensuring the quality and safety of drugs in the rapidly advancing technological landscape. The research is based on a thorough review of the literature, supplemented by case studies, and provides insights into the data security scheme required for pharmaceutical companies' traceability processes. It also highlights the various steps involved in the traceability procedures, which have the potential to produce data and involve multiple participants. Effective technical security measures should be employed to manage and use the data to ensure its security and provide tools for maintaining drug quality. Also, the study highlights the technical foundation required to implement data security management, including blockchain and data security technology in the various data states analyzed, provides valuable management insights for medical enterprises or institutions, and explores the realization principles of various data security technologies in conjunction with blockchain technology. The research provides a comprehensive application of literature and cases and serves as a guide for enterprises' actual data security management, providing resources for pharma companies undergoing digital transformation to make strategic decisions about information management. Overall, the study offers valuable insights for learning lessons and generating new ideas in pharmaceutical traceability.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.